Media
Focus on the development of new antibody drugs for the treatment of tumors and autoimmune inflammatory diseases

Media

新闻动态
Homepage
/
News
/
Press Release
/
Jun.19th, 2020 HJB and Kanova Biopharma reached strategic collaboration

Jun.19th, 2020 HJB and Kanova Biopharma reached strategic collaboration

  • Categories:Press Release
  • Author:
  • Origin:
  • Time of issue:2020-08-20 14:18
  • Views:

(Summary description)Jun.19th, 2020 HJB and Kanova Biopharma reached strategic collaboration

Jun.19th, 2020 HJB and Kanova Biopharma reached strategic collaboration

(Summary description)Jun.19th, 2020 HJB and Kanova Biopharma reached strategic collaboration

  • Categories:Press Release
  • Author:
  • Origin:
  • Time of issue:2020-08-20 14:18
  • Views:
Information

Jun.19th, 2020 HJB and Kanova Biopharma reached strategic collaboration

Scan the QR code to read on your phone

Previous: None
Next: Feb.19th, 2020 The IND application of “Recombinant anti-human IL-17A / F humanized monoclonal antibody injection” is approved by NMPA.
Previous: None
Next: Feb.19th, 2020 The IND application of “Recombinant anti-human IL-17A / F humanized monoclonal antibody injection” is approved by NMPA.
这是描述信息

Add

Zhong Guancun Biopharmaceutical Park, NO.5 Kaituo Road,

Haidian District, Beijing City, China, 10084

A1 Northern Building, 218 Xinghu St. Suzhou Industrial Park, Jiangsu Province, China, 215123

COPYRIGHT @2020 Suzhou xinkanghe Biomedical Technology Co., Ltd   苏ICP备19068714号-1   Power by 300.cn Beijing

这是描述信息

Follow us